|
|
|
|
| LEADER |
03009nam a2200493 4500 |
| 001 |
978-3-030-16814-8 |
| 003 |
DE-He213 |
| 005 |
20191026001039.0 |
| 007 |
cr nn 008mamaa |
| 008 |
190726s2019 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783030168148
|9 978-3-030-16814-8
|
| 024 |
7 |
|
|a 10.1007/978-3-030-16814-8
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a QR1-502
|
| 072 |
|
7 |
|a PSG
|2 bicssc
|
| 072 |
|
7 |
|a SCI045000
|2 bisacsh
|
| 072 |
|
7 |
|a PSG
|2 thema
|
| 082 |
0 |
4 |
|a 579
|2 23
|
| 245 |
1 |
0 |
|a Lichen Secondary Metabolites
|h [electronic resource] :
|b Bioactive Properties and Pharmaceutical Potential /
|c edited by Branislav Ranković.
|
| 250 |
|
|
|a 2nd ed. 2019.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2019.
|
| 300 |
|
|
|a V, 260 p. 19 illus., 12 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
|
|a Lichens as a potential source of bioactive secondary metabolites -- Lichens used in traditional medicine -- Lichen secondary metabolites as potential antibiotic agents -- Studies on antioxidant properties of lichen secondary metabolites -- Investigations of lichen secondary metabolites with potential anticancer activity -- Antigenotoxic effect of some lichen metabolites -- Lichen secondary metabolites as possible antiviral agents -- Future directions in the study of pharmaceutical potential of lichens.
|
| 520 |
|
|
|a This revised and extended edition provides in-depth insights into the benefits and untapped potential of lichen-derived bioactive compounds. The whole spectrum of these compounds' biological and medical functions, from antibiotic to antiviral and anti-carcinogenic properties, is presented. In addition, a new chapter discusses the anti-neurodegenerative and anti-diabetic activities of lichenic secondary metabolites. Given its scope, the book offers a valuable asset for students and researchers in this field.
|
| 650 |
|
0 |
|a Microbiology.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Mycology.
|
| 650 |
1 |
4 |
|a Eukaryotic Microbiology.
|0 http://scigraph.springernature.com/things/product-market-codes/L23020
|
| 650 |
2 |
4 |
|a Applied Microbiology.
|0 http://scigraph.springernature.com/things/product-market-codes/C12010
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|0 http://scigraph.springernature.com/things/product-market-codes/B21007
|
| 650 |
2 |
4 |
|a Mycology.
|0 http://scigraph.springernature.com/things/product-market-codes/L27000
|
| 700 |
1 |
|
|a Ranković, Branislav.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783030168131
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783030168155
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783030168162
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-030-16814-8
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
